metabolic drugs

Measuring tape on top of cash
Biotech

Zealand pens $2.5B cardiometabolic collab with Chinese biotech

OTR may be keeping its own pipeline under wraps, but Zealand has seen enough promise in the Chinese biotech’s platform to hand over up to $30 million.
James Waldron Dec 11, 2025 5:45am
Goal disorientation and lack of vision

Lilly pens $1.2B pact with Sanegene to target metabolic RNA meds

Nov 10, 2025 4:05am
Metallic arrow symbols which are illuminated by blue and magenta lights merge on blue and magenta b

Barinthus enters reverse merger with metabolic disease biotech

Sep 30, 2025 10:39am
Illustration of the concept of layoff and downsizing of staff

Biomea cuts staff, drops leukemia asset in metabolic shift

May 5, 2025 6:59pm
deal handshake biotech deal pharma deal biopharma deal

Novo taps Photys for multi-molecule cardiometabolic collab

Dec 18, 2024 7:30am
proclaim red announcement

Aligos MASH prospect slashes liver fat in phase 2

Sep 19, 2024 1:00pm